Category:Cancer treatments
From WikiMD's Wellness Encyclopedia
 | Pages in this category should be moved to subcategories where applicable. This category may require frequent maintenance to avoid becoming too large. It should directly contain very few, if any, pages and should mainly contain subcategories. |
Subcategories
This category has the following 2 subcategories, out of 2 total.
Pages in category "Cancer treatments"
The following 200 pages are in this category, out of 527 total.
(previous page) (next page)3
A
- Abituzumab
- Abstral
- ABT-510
- Active immunotherapy
- ADE (chemotherapy)
- Adecatumumab
- Adegramotide
- ADH-1
- Adjuvant therapy
- Adjuvant chemotherapy
- Adoptive immunotherapy
- ADXS11-001
- Aldesleukin
- ALK inhibitor
- Alkylating antineoplastic agents
- Alpelisib
- ALT-803
- Alternating electric field therapy
- Altumomab pentetate
- Amatuximab
- AMG 319
- Amphinex
- ANG1005
- Angiostatin
- Annamycin
- Anti-idiotypic vaccine
- Anti-VEGF
- Antiangiogenesis
- Antiangiogenic
- Antibody-drug conjugate
- Antibody-drug conjugates
- Antibody–drug conjugate
- Antihormone therapy
- Template:Antineoplastic-agents-stub
- Antineoplastics
- Apatinib
- Aromatase Inhibitor
- Artificial fever
- Asparaginase erwinia chrysanthemi
- Atrasentan
- Auger therapy
- Autologous immune enhancement therapy
- Autologous tumor cell
- Avapritinib
- Avicine
- Axicabtagene ciloleucel
B
C
- C-1027
- Camidanlumab tesirine
- Cancer Chemotherapy and Pharmacology
- Cancer drugs
- Cancer therapy
- Cantuzumab
- Capmatinib
- Capsaicin
- CAR T cell
- CAR T-cell therapy
- Carmustine
- Carmustine implant
- Catumaxomab
- Cellular adoptive immunotherapy
- Chemo
- Chemosensitizer
- Chemotherapeutic
- Chemotherapy
- Chemotherapy drug
- Chimeric antigen receptor
- Chimeric antigen receptor T cell
- Cirmtuzumab
- Cisplatin
- Citatuzumab
- Cixutumumab
- Clevegen
- Clostridium novyi-NT
- Cofetuzumab pelidotin
- Coley's toxins
- Combinatorial ablation and immunotherapy
- Combined photothermal and photodynamic therapy
- Conatumumab
- Conization
- Continuous hyperthermic peritoneal perfusion
- Cryoimmunotherapy
- Cryosurgery
- Custirsen
- Cyberknife (device)
- Cytarabine
- Cytostatic
D
- Dabrafenib
- Dacarbazine
- Dacetuzumab
- Dactolisib
- Dalantercept
- Dalotuzumab
- DAT (chemotherapy)
- Debulking
- Defactinib
- Demcizumab
- Dendritic cell-based cancer vaccine
- Detumomab
- Devimistat
- Dinutuximab beta
- Discovery and development of tubulin inhibitors
- Donor lymphocyte infusion
- Dose-dense chemotherapy
- Duligotumab
- Dusigitumab
E
- EBC-46
- Ecromeximab
- Edrecolomab
- Electrochemotherapy
- Emtansine
- Encorafenib
- Endocrine therapy
- Endoscopic mucosal resection
- Endostatin
- Engineered CAR T cell delivery
- Enoblituzumab
- Ensituximab
- Erlizumab
- Ertumaxomab
- Estrogen deprivation therapy
- Etoposide
- Etoposide phosphate
- Exagamglogene autotemcel
- Exherin
- Extracorporeal photopheresis
